ARTICLE | Clinical News
PEP005 topical ingenol mebutate gel: Phase IIb start
June 16, 2008 7:00 AM UTC
This month, Peplin plans to start a double-blind, placebo-controlled, international Phase IIb (PEP005-015) trial to evaluate PEP005 gel applied once daily for 2 or 3 consecutive days in 240 patients w...